The FDA approved a therapy from Revolution Medicines that slows a cancer that kills 7 of out 8 patients within five years. on.wsj.com/4d2fC18

How each outlet headlined it

• The Wall Street Journal right

  The FDA approved a therapy from Revolution Medicines that slows a cancer that kills 7 of out 8 patients within five years. on.wsj.com/4d2fC18
• Reuters

  Revolution Medicines gets FDA nod for targeted pancreatic cancer drug reut.rs/3U8SYhn
• Bloomberg News center

  Revolution Medicines secured US regulatory approval for its pancreatic cancer drug daraxonrasib, the first medicine to target one of the key molecular causes of the disease.
• The New York Times left

  Breaking News: The FDA approved a first-of-its-kind pill that could substantially extend the lives of patients with pancreatic cancer.
• STAT

  The FDA has approved a life-extending treatment for advanced pancreatic cancer — the first such therapy to attack a genetic cause of the highly lethal malignancy. www.statnews.com/2026/08/26/p...
• CNBC left

  Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
• Investor's Business Daily right

  Revolution Medicines won FDA approval Wednesday for the pancreatic cancer treatment that once caused its stock to skyrocket. The post FDA Approves 'Unprecedented' Pancreatic Cancer Drug appeared first on Investor's Business Daily.
• The Guardian left

  FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer The US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of the disease. FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumor growth in more than 90% of pancre
• CNN left

  The US FDA has approved Revolution Medicines' targeted drug for adults with ​metastatic pancreatic cancer who have received prior treatment or ‌cannot receive combination chemotherapy. https://cnn.it/3UWB6q3
• Investing.com Stocks

  Revolution’s lifesaving pancreatic cancer drug wins speedy FDA approval
• The Hill center

  The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer. The once-daily pill, called daraxonrasib and manufactured by Revolution Medicines, will be sold under the brand name Rasonque. It was approved for patients who already tried…
• Medical Xpress

  Since the passage of the 21st Century Cures Act in 2016, Food and Drug Administration (FDA) approvals for new medical products have relied on fewer studies, according to a study published Aug. 26, 2026, in the PLOS ONE by researchers from the Stanford University School of Medicine Clinical Excellence Research Center, Oregon State University and UCLA, U.S.